Fortress Biotech, Inc. (FBIO): Expected earnings per share growth for next year

Public company logo of Fortress (FBIO)

Fortress Biotech, Inc. (FBIO) brings together leading M&A experts and biopharma strategists, utilizing an equity participation system to retain talent. The historical trend of n+1 profit forecasts demonstrates volatility in expectations, where the value -138.60 captures this metric. The incubator model commercializes patents through subsidiary structures, while asset portfolio diversification minimizes risks associated with the failure of individual developments.

Fortress Biotech Corp (FBIO): Consensus forecast of earnings per share growth for next year from 07/04/2022 to 11/15/2026

Metric breakdowns and analytics for Fortress Biotech Inc (FBIO)

- price and consensus price forecast:
Price Chart Fortress Biotech Inc|FBIO - Average Forecast Price
- stock exchange capitalization data:
Market Valuation Fortress Biotech, Inc.|FBIO - Enterprise Value
- book capitalization information:
Net Assets per Single Share Fortress Biotech|FBIO - Book Valuation of Business|Market Cap to Net Assets Ratio fortressbiotech.com|FBIO - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Fortress Biotech, Inc.|FBIO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Fortress Biotech, Inc.|FBIO - Company Aggregate Debt|Debts to Book Capitalization Fortress|FBIO - Company Long-Term Liabilities|Company Short-Term Debt Fortress Biotech|Quick Liquidity fortressbiotech.com
- net income and valuation ratios data:
FBIO - Company Net Income|Expected Profit Fortress Biotech, Inc.|FBIO - Market Cap to Earnings|Forward P/E Multiple fortressbiotech.com|FBIO - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Fortress Biotech|FBIO - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Fortress Biotech|FBIO - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months fortressbiotech.com|FBIO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Fortress Biotech, Inc.
- revenue and sales details:
FBIO - Company Sales Revenue|Company Future Sales Volume Fortress|FBIO - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio Fortress|FBIO - Revenue Dynamics YoY (Last Twelve Months)
General company analysis:fortressbiotech.com, FBIO
Core merchandise of Fortress Biotech

Fortress Biotech, Inc. (FBIO) maintains operational resilience by outsourcing production through a network of CDMO plants, which minimizes capital expenditures. The eps_nexty_co trend measures the consensus forecast for earnings growth rates for the coming year, reflecting analysts' confidence in the business's scalability. Narrowing volatility in current expectations for the n+1 EPS growth rate signals stabilizing valuations and the market's preparation for a new price impulse.

Analysis of competing companies

Net earnings per share growth forecast for next year NovoCure Ltd|Expected net earnings per share growth next year Alpha Tau Medical DRTS|Expected earnings per share growth for next year ACRV (acrivon.com)|Earnings growth forecast for next year Allarity Therapeutics Inc. (ALLR)